Gastrointestinal tumours, non-colorectal
Invited discussant abstracts 620PD, 621PD and 622PD
Date
08 Oct 2016Session
Gastrointestinal tumours, non-colorectalPresenters
Eduardo Diaz RubioAuthors
E. Diaz RubioAuthor affiliations
- Oncologia Medica, Hospital Clinico Universitario San Carlos, 28040 - Madrid/ES
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
870 - A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)
Presenter: Elizabeth Smyth
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
2637 - Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis
Presenter: Jing Huang
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
2823 - Phase III study comparing intraperitoneal paclitaxel plus S-1/paclitaxel with S-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
Presenter: Yoshiyuki Fujiwara
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Invited discussant abstracts LBA26, LBA27 and 616PD
Presenter: Eric Van Cutsem
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
1861 - Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Prognosis, efficacy, and safety by liver disease etiology
Presenter: Takuji Okusaka
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
3822 - Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial
Presenter: Jordi Bruix
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4066 - Molecular characteristics of hepatocellular carcinomas (HCC) from different age groups
Presenter: Celina Ang
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
2268 - Prognostic factors in curative treatment of gallbladder cancer - Data of 950 cases of “The German- Registry”
Presenter: Thorsten Goetze
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Invited discussant abstracts 617PD, 618PD, 619PD and LBA28
Presenter: Florian Lordick
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
2212 - Comparative molecular analyses of pancreatic cancer (PC): Younger vs. older patients (pts)
Presenter: Mohamed Salem
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract